Inverness Medical Innovations to Participate at JP Morgan Healthcare
Conference on January 13, 2009
WALTHAM, Mass., Dec. 30 /PRNewswire-FirstCall/ -- Inverness Medical
Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics,
monitoring and health management solutions, announced today that it will
attend the upcoming JP Morgan Healthcare Conference being held January 12
through 15, 2009 at the Westin St. Francis Hotel in San Francisco. Ron
Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance,
will attend. Mr. Zwanziger's presentation is scheduled for Tuesday, January
13, 2009 at 3:00 p.m. PT, and will be made available to the public through a
webcast accessible via
http://metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=IMA,
as well as through the company's website at
http://www.invmed.com/investors.cfm. A replay of the webcast will be
available via the links above for approximately 3 months from the date of the
webcast. During his presentation, Mr. Zwanziger or Mr. Russell may discuss
and answer questions concerning business and financial developments and
trends. Their responses to questions, as well as other matters discussed
during the webcast, may contain or constitute information that has not been
disclosed previously.
Prior to the conference the Company will also be posting an updated investor
presentation on its website at www.invmed.com/presentations.cfm.
By developing new capabilities in near-patient diagnosis, monitoring and
health management, Inverness Medical Innovations enables individuals to take
charge of improving their health and quality of life. A global leader in
rapid point-of-care diagnostics, Inverness' products, as well as its new
product development efforts, focus on infectious disease, cardiology,
oncology, drugs of abuse and women's health. Inverness is headquartered in
Waltham, Massachusetts.
SOURCE Inverness Medical Innovations, Inc.
Doug Guarino, Director of Corporate Relations of Inverness Medical
Innovations, Inc., +1-781-647-3900
